{
    "root": "b216cb2c-ff72-4b54-9486-404a23092128",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Mesna",
    "value": "20250302",
    "ingredients": [
        {
            "name": "mesna",
            "code": "NR7O1405Q9"
        },
        {
            "name": "edetate disodium",
            "code": "7FLD91C86K"
        },
        {
            "name": "benzyl alcohol",
            "code": "LKG8494WBH"
        },
        {
            "name": "sodium hydroxide",
            "code": "55X04QC32I"
        },
        {
            "name": "water",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "Mesna Injection is indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis.",
    "contraindications": "Mesna injection may be given on a fractionated dosing schedule of three bolus intravenous injections or a single bolus injection followed by two oral administrations of mesna tablets as outlined below. The dosing schedule should be repeated on each day that ifosfamide is administered.  When the dosage of ifosfamide is adjusted, the ratio of mesna to ifosfamide should be maintained. ( 2 ) Intravenous Dosing Schedule: 0 Hours 4 Hours 8 Hours Ifosfamide 1.2 g/m 2 - - Mesna injection 240 mg/m 2 240 mg/m 2 240 mg/m 2 Intravenous and Oral Dosing Schedule: 0 Hours 2 Hours 6 Hours Ifosfamide 1.2 g/m 2 - - Mesna injection 240 mg/m 2 - - Mesna tablets - 480 mg/m 2 480 mg/m 2 Maintain sufficient urinary output, as required for ifosfamide treatment, and monitor urine for the presence of hematuria. ( 2.3 )",
    "warningsAndPrecautions": "Mesna Injection is supplied as follows:\n\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              NDC\n                           \n                           \n                              Mesna Injection (100 mg per mL)\n                           \n                           \n                              Package Factor\n                           \n                        \n                        \n                           25021-201-10\n\n                           1 gram per 10 mL Multi-Dose Vial\n\n                           1 vial per carton\n\n                        \n                        \n                           25021-201-11\n\n                           1 gram per 10 mL Multi-Dose Vial\n\n                           10 vials per carton",
    "adverseReactions": "Mesna is contraindicated in patients known to be hypersensitive to mesna or to any of the excipients [see Warnings and Precautions (5.1)]."
}